Sage Journals: Discover world-class research

Retricted access

Review article

First published 2021-9

Satralizumab for the Treatment of Neuromyelitis Optica Spectrum Disorders

Yanli Gao, Baoqi Zhang, Junyi Yang

Annals of Pharmacotherapy

Retricted access

Case report

First published 2023-1

Severe febrile neutropenia associated with satralizumab in an Argentinian neuromyelitis optica spectrum disorder patient

Claudia Pestchanker, Melina Diaconchuk, Paula Lopez [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2025-10

Satralizumab treatment in adults with aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder in clinical practice

Hesham Abboud, Brian Steingo, Diana Vargas [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2026-3

Long-term effectiveness and safety of satralizumab for neuromyelitis optica spectrum disorder in a real-world clinical setting in Japan: A 2.5-year final analysis of a multicenter medical chart review (The SAkuraBeyond Study)

Kazuo Fujihara, Noriko Isobe, Katsuichi Miyamoto [...]

Multiple Sclerosis Journal

Open access

Case report

First published 2023-12

Therapy challenges for NMOSD in a patient with HIV

Daniel Engels, Joachim Havla, Stefanie Förderreuther [...]

Multiple Sclerosis Journal

Retricted access

Case report

First published 2023-1

Severe febrile neutropenia associated with satralizumab in an Argentinian NMOSD patient—Commentary

Cristina Valencia-Sanchez

Multiple Sclerosis Journal

Retricted access

Research article

First published 2023-5

Humoral COVID-19 vaccine response in patients with NMOSD/MOGAD during anti-IL-6 receptor therapy compared to other immunotherapies

Carolin Schwake, Thivya Pakeerathan, Ingo Kleiter [...]

Multiple Sclerosis Journal

Retricted access

Case report

First published 2025-10

Long-standing gadolinium enhancement in a patient with aquaporin-4-positive myelitis

Aliénor Jaillard, Elisabeth Maillart, Natalia Shor

Multiple Sclerosis Journal

Retricted access

Research article

First published 2026-2

Place of anti-IL6R in the therapeutic strategy in NMOSD-AQP4+,MOGAD,and NMOSD double-seronegative patients

Chloé Comet, Guillaume Jouvenot, Bertrand Bourre [...]

Multiple Sclerosis Journal

Open access

Review article

First published 2024-01

Advances in the long-term treatment of neuromyelitis optica spectrum disorder

Monique Anderson, Michael Levy

Journal of Central Nervous System Disease

Search results